Related Experiment Video
Updated: Jun 8, 2025

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
Published on: December 5, 2015
Development and Validation of a Predictive Model for Maternal Cardiovascular Morbidity Events in Patients With
Marie-Louise Meng1, Yuqi Li2, Matthew Fuller1,3
1From the Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina.
Insights
This study developed a predictive model for cardiovascular events in patients with hypertensive disorders of pregnancy (HDP). The model accurately predicts acute complications during delivery and within one year postpartum.
Area of Science:
- Cardiology
- Obstetrics
- Data Science
Background:
- Hypertensive disorders of pregnancy (HDP) significantly increase maternal morbidity, mortality, and long-term cardiovascular disease risk.
- Predicting acute cardiovascular (CV) complications in pregnant individuals with HDP remains a challenge.
- Comorbid conditions are key predictors of CV risk in this population.
Purpose of the Study:
- To develop and validate a predictive model for all CV events, specifically heart failure, renal failure, and cerebrovascular events, following HDP.
- To identify individuals with HDP at high risk for acute CV complications during hospitalization and readmission.
Main Methods:
- Utilized the Premier Healthcare Database for deliveries with HDP between October 2015 and December 2020.
- Employed machine learning, specifically multilabel neural networks, to create predictive models for in-hospital and readmission CV events.
- Models were trained on 60% of data, validated on 20%, and tested on 20% to evaluate performance.
Main Results:
- The study cohort included 553,658 deliveries with HDP; 1.2% experienced a CV event during hospitalization.
- The Index Model demonstrated strong predictive performance (AUROC 0.878 for all CV events).
- The Readmission Model showed fair predictive performance (AUROC 0.717 for all CV events); chronic renal disease, cardiac disease, and pulmonary hypertension were key predictors.
Conclusions:
- A multilabel neural network model effectively predicted cardiovascular events during delivery admission for individuals with HDP.
- The model also provided fair classification for cardiovascular events occurring within one year postpartum.
Background:
Hypertensive disorders of pregnancy (HDP) are a major contributor to maternal morbidity, mortality, and accelerated cardiovascular (CV) disease. Comorbid conditions are likely important predictors of CV risk in pregnant people. Currently, there is no way to predict which people with HDP are at risk of acute CV complications. We developed and validated a predictive model for all CV events and for heart failure, renal failure, and cerebrovascular events specifically after HDP.
Methods:
Models were created using the Premier Healthcare Database. The inclusion criteria for the model dataset were delivery with an HDP with discharge from October 1, 2015 to December 31, 2020. Machine learning methods were used to derive predictive models of CV events occurring during delivery hospitalization (Index Model) or during readmission (Readmission Model) using a training set (60%) to estimate model parameters, a validation set (20%) to tune model hyperparameters and select a final model, and a test set (20%) to evaluate final model performance.
Results:
The total model cohort consisted of 553,658 deliveries with an HDP. A CV event occurred in 6501 (1.2%) of the delivery hospitalizations. Multilabel neural networks were selected for the Index Model and Readmission Model due to favorable performance compared to alternatives. This approach is designed for prediction of multiple events that share risk factors and may cooccur. The Index Model predicted all CV events with area under the receiver operating curve (AUROC) 0.878 and average precision (AP) 0.239 (cerebrovascular events: AUROC 0.941, heart failure: AUROC 0.898, and renal failure: AUROC 0.885). With a positivity threshold set to achieve ≥90% sensitivity, model specificity was 65.0%, 83.5%, 68.6%, and 65.6% for predicting all CV events, cerebrovascular events, heart failure, and renal failure, respectively. CV events within 1 year of delivery occurred in 3018 (0.6%) individuals. The Readmission Model predicted all CV events with AUROC 0.717 and AP 0.022 (renal failure: AUROC 0.748, heart failure: AUROC 0.734, and cerebrovascular events AUROC 0.698). Feature importance analysis indicated that the presence of chronic renal disease, cardiac disease, pulmonary hypertension, and preeclampsia with severe features had the greatest effect on the prediction of CV events.
Conclusions:
Among individuals with HDP, our multilabel neural network model predicted CV events at delivery admission with good classification and events within 1 year of delivery with fair classification.
Related Concept Videos
Mitral Valve Prolapse III: Nursing Management
Hypertension and Regulation of Blood Pressure
Pre-Procedural Guidelines for Assessing Blood Pressure
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

